PLXND1 and systemic sclerosis: In addition, the phosphorylated form of PlxnD1 significantly increased in H-MVECs challenged with sera from patients with SSc compared with both basal H-MVECs and H-MVECs cultured with sera from healthy controls (both p <0.05) (Fig. 5a).